Trial II of Lung Protection With Azithromycin in the Preterm Infant

PHASE2CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Bronchopulmonary Dysplasia
Interventions
DRUG

Azithromycin

Give 10 mg/kg IV/PO daily for first 7 days, then give 5 mg/kg IV/PO daily for 35 days.

DRUG

Placebo

vehicle dose given daily, IV/PO, same volume that Azithromycin would be to equal 10 mg/kg for first 7 days, then 5 mg/kg for 5 weeks.

Trial Locations (1)

40536

University of Kentucky Medical Center, Lexington

All Listed Sponsors
collaborator

American Lung Association

OTHER

lead

Hubert Ballard

OTHER

NCT00319956 - Trial II of Lung Protection With Azithromycin in the Preterm Infant | Biotech Hunter | Biotech Hunter